Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over 5 years in US-based infrastructure, ensuring all key Novartis medicines for US patients will be made in the United States. This commitment enables Novartis to expand on its current manufacturing, research and techn…
Amcor a global leader in developing and producing responsible packaging solutions, today announced that it has completed construction of its advanced coating facility for healthcare packaging in Selangor, Malaysia. This state-of-the-art facility is the first in Asia to leverage cutting-edge air knife coating technolog…
BDD has opened its new 122m² GMP manufacturing facility at BioCity near Glasgow, following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) in March 2025. Two years in the making, the development of the state-of-the-art facility was facilitated by a funding round of £2 mill…
Siemens will be responsible for developing industrial applications, buildings, infrastructure, and utilities for Miko Pharma’s operations in Eastern Ghana, adhering to stringent World Health Organization standards. “Our goal is to enable the manufacture of safe pharmaceutical drugs in Africa. This partnership with Mi…
Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced its foray into Cell & Gene Therapy (CGT) & Viral Vector Production at Genome Valley - expanding its expertise from vaccine innovation to leading-edge regenerative and personalised th…
NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint in Switzerland’s biotech ecosystem. NBE Therapeutics, a Swiss biotech founded in 2012 that…
Corundum Systems Biology (CSB), a leading investment company dedicated to advancing life-changing systems biology solutions for human health and well-being, announced the opening of its first office in the U.S. Located at CIC Cambridge, One Broadway, in Cambridge, MA, the new office brings CSB even closer to innovator…
SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility in North Charleston, South Carolina. This strategic expansion marks a significant milestone in the Swiss-based company's global gro…
Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions. The project entails the revitalization of this historical production site, first establis…
Biogen Inc. announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in Massachusetts. The move centralizes Biogen’s presence in Kendall Square, integrating Biogen’s research and development and technical operations t…
Page 28 of 63